Mild Cognitive Impairment (MCI) clinical trials in Massachusetts
26 active Mild Cognitive Impairment (MCI) trials with a site in Massachusetts. Describe your situation to see which ones look like a fit.
- Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Mindfulness for Cognition in Early-stage Alzheimer's Disease
- Individual Closed-Loop Neuromodulation Therapy for Alzheimer's Disease
- Healthy Aging as Black Adults, In It Together: a Comparative Effectiveness Study of Chronic Pain and Cognitive Decline
- Treating Insomnia in Mild Cognitive Impairment
- Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population
- Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
- Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
- Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
- Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
- AI-CONECT: A Conversational AI for Early Dementia Prevention in Socially-Isolated Older Adults
- Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
- Alzheimer's Disease Neuroimaging Initiative 4
- Alzheimer's Registry
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- Impact of Intensive Computerized Cognitive Training
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.